Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medical composition

A composition and drug technology, which can be used in drug combinations, pharmaceutical formulations, cardiovascular system diseases, etc., and can solve problems such as high cost and inappropriate operation.

Inactive Publication Date: 2009-09-02
吉林华康药业股份有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, if the coronary artery disease is scattered, it is not suitable for surgery. In addition, surgical treatment is more expensive than drug treatment, and drug maintenance treatment is still required after surgery.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical composition
  • Medical composition
  • Medical composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Pseudo-ginsenoside GQ 60.0g

[0034] Propylene glycol 2000ml

[0035] Preparation process Take 60.0g of pseudo-ginsenoside GQ crude drug, add 2000ml of propylene glycol, heat and dissolve at 60-80°C, filter, pot, sterilize with damp heat at 121°C for 15min, sub-package, and make 1000 sticks, pH value is 4.0 -6.0.

Embodiment 2

[0037] Pseudo-ginsenoside GQ 0.2g

[0038] Propylene glycol 2000ml

[0039] Preparation process Take 0.2g of pseudo-ginsenoside GQ crude drug, add 2000ml of propylene glycol, heat and dissolve at 60-80°C, filter, pot, sterilize with damp heat at 121°C for 15min, sub-package, and make 1000 sticks, pH value is 4.0 -6.0.

Embodiment 3

[0041] Pseudo-ginsenoside GQ 200g

[0042] Propylene glycol 2000ml

[0043] Take 200g of pseudo-ginsenoside GQ crude drug, add 2000ml of propylene glycol, heat and dissolve at 60-80°C, filter, pot, sterilize with damp heat at 121°C for 15min, and pack to make 1000 tubes, with a pH value of 4.0-6.0.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medical composition which belongs to a medical preparation. The medical composition is prepared from 0.01 percent to 10 percent (w / v) of pseudo-ginsenoside GQ and medical-acceptable solution, and the pH value is from 3.0 to 7.0. The invention has the advantages that the whole-body active allergic reaction of the pseudo-ginsenoside GQ injection liquid is negative, and the passive skin allergic test reaction of the pseudo-ginsenoside GQ is negative. The injection liquid is stable and has good clarity. The lyopilization powder is stable.

Description

technical field [0001] The invention belongs to a kind of pharmaceutical preparation. Background technique [0002] Myocardial ischemia (MI) is the result of an imbalance between the supply and demand of myocardial oxygen. On the one hand, due to insufficient coronary blood supply, on the other hand, excessive demand results in a lack of oxygen and nutrients in myocardial tissue, resulting in myocardial metabolism and dysfunction. Ischemia causes oxidative metabolic disorder, promotes anaerobic metabolism and leads to the accumulation of harmful products of anaerobic metabolism such as lactic acid, causing poisoning. Clinical manifestations of myocardial ischemia include angina pectoris, acute myocardial infarction, and asymptomatic myocardial ischemia with ischemic ECG changes. [0003] According to the "China Cardiovascular Disease Report 2006" report, China is in a period of economic transition, the national economy is developing rapidly, and people's lifestyles have un...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/704A61P9/10
Inventor 李平亚刘金平刘传贵朱继忠金立群
Owner 吉林华康药业股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com